Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease

Virchows Archiv

Volumn 446, Issue 3, 2005, Pages 287-299

  Kalinski, Thomas ^a   Krueger, Sabine ^a   Pelz, Antje Friederike ^a   Wieacker, Peter ^a   Hartig, Roland ^a   Röpke, Martin ^a   Schneider Stock, Regine ^a   Dombrowski, Frank ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cell line; Ollier's disease; Secondary chondrosarcoma

Indexed keywords

AGGRECAN; CATHEPSIN B; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; GELATINASE A; MATRIGEL; PROTEINASE; UROKINASE;

ADULT; ARTICLE; CARTILAGE TUMOR; CASE REPORT; CHONDROSARCOMA; CHORIOALLANTOIS; CHROMOSOME ANALYSIS; ENCHONDROMATOSIS; HUMAN; HUMAN CELL CULTURE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR CELL LINE; TUMOR MODEL;

ADULT; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROSARCOMA; CHORIOALLANTOIC MEMBRANE; CHROMOSOME ABERRATIONS; ENCHONDROMATOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 17644403516     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1194-y     Document Type: Article

References (41)

1. Aigner T, Dertinger S, Vornehm SI, Dudhia J, von der Mark K, Kirchner T (1997) Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol 150:2133-2141
2. Aigner T, Muller S, Neureiter D, Illstrup DM, Kirchner T, Bjornsson J (2002) Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 94:2273-2281
3. Barch MJ (ed) (1991) The ACT Cytogenetics laboratory manual, 2nd edn. Raven Press, New York
4. Bertoni F, Bacchini P, Hogendoorn PCW (2002) Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 247-251
5. Bovee JV, van Roggen JF, Cleton-Jansen AM, Taminiau AH, van der Woude HJ, Hogendoorn PC (2000) Malignant progression in multiple enchondromatosis (Ollier's disease): an autopsybased molecular genetic study. Hum Pathol 31:1299-1303
6. Bovee JV, van Royen M, Bardoel AF, Rosenberg C, Cornelisse CJ, Cleton-Jansen AM, Hogendoorn PC (2000) Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol 157:1587-1595
7. Bridge JA, Bhatia PS, Anderson JR, Neff JR (1993) Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet 69:79-90
8. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991) Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:137-144
9. Chano T, Okabe H, Saeki Y, Ishizawa M, Matsumoto K, Hukuda S (1998) Characterization of a newly established human chondrosarcoma cell line, CS-OKB. Virchows Arch 32:529-534
10. Chansky H, Robbins JR, Cha S, Raskind WH, Conrad EU, Sandell LJ (1998) Expression of cartilage extracellular matrix and potential regulatory genes in a new human chondrosarcoma cell line. J Orthop Res 16:521-530
11. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
12. Deryugina EI, Luo GX, Reisfeld RA, Bourdon MA, Strongin A (1997) Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 17:3201-3210
13. Dorfman HD, Czerniak B (1998) Bone Tumors. Mosby Inc., St. Louis
14. Duffy MJ (1992) The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10:145-155
15. Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res 2:613-618
16. Elima K, Vuorio E (1989) Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett 258:195-198
17. Erlandson RA, Huvos AG (1974) Chondrosarcoma: a light and electron microscopic study. Cancer 34:1642-1652
18. Gil-Benso R, Lopez-Gines C, Lopez-Guerrero JA, Carda C, Callaghan RC, Navarro S, Ferrer J, Pellin A, Llombart-Bosch A (2003) Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin. Lab Invest 83:877-887
19. Hackel C, Czerniak B, Ayala AG, Radig K, Roessner A (1997) Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma. Cancer 79: 53-58
20. Hackel CG, Krueger S, Grote HJ, Oshiro Y, Hodges S, Johnston DA, Johnson ME, Roessner A, Ayala AG, Czerniak B (2000) Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Cancer 89: 995-1003
21. Krueger S, Kellner U, Buehling F, Roessner A (2001) Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Cancer Gene Ther 8:522-528
22. Kunisada T, Miyazaki M, Mihara K, Gao C, Kawai A, Inoue H, Namba M (1998) A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 77:854-859
23. Kunzi-Rapp K, Genze F, Kufer R, Reich E, Hautmann RE, Gschwend JE (2001) Chorioallantoic membrane assay: vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. J Urol 166:1502-1507
24. Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE, Jennings LC (1999) Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81:326-338
25. Liu J, Hudkins PG, Swee RG, Unni KK (1987) Bone sarcomas associated with Ollier's disease. Cancer 59:1376-1385
26. Mackinnon WB, Hancock R, Dyne M, Russell P, Mountford CE (1992) Evaluation of an in vitro invasion assay for use on solid tissue samples and cultured cells. Invasion Metastasis 12:241-252
27. Mandahl N, Gustafson P, Mertens F, Akerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HC, Larsson O (2002) Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer 33:188-200
28. Mertens-F, Unni-K (2002) Enchondromatosis: Ollier disease and Mafucci syndrome. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 356-357
29. Mitelman F (1995) An international system for human cytogenetic nomenclature. S. Karger, Basel
30. Ozisik YY, Meloni AM, Spanier SS, Bush CH, Kingsley KL, Sandberg AA (1998) Deletion 1p in a low-grade chondrosarcoma in a patient with Oilier disease. Cancer Genet Cytogenet 105:128-133
31. Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS, Carbone M (1996) Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63:37-50
32. Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M (1999) Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma. J Cancer Res Clin Oncol 125:541-548
33. Sambrook J, Russell DW (2001) Molecular cloning. Cold Spring Harbor Laboratory Press, New York
34. Sameni M, Dosescu J, Moin K, Sloane BF (2003) Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Mol Imaging 2:159-175
35. Schajowicz F, Cabrini RL, Simes RJ, Klein-Szanto AJ (1974) Ultrastructure of chondrosarcoma. Clin Orthop 100:378-386
36. Schneider-Stock R, Boltze C, Lasota J, Miettinen M, Peters B, Pross M, Roessner A, Gunther T (2003) High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 21:1688-1697
37. Soderstrom M, Aro HT, Ahonen M, Johansson N, Aho A, Ekfors T, Bohling T, Kahari VM, Vuorio E (2001) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS 109:305-315
38. Takigawa M, Tajima K, Pan HO, Enomoto M, Kinoshita A, Suzuki F, Takano Y, Mori Y (1989) Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res 49:3996-4002
39. Ueda Y, Oda Y, Tsuchiya H, Tomita K, Nakanishi I (1990) Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone. Virchows Arch 417:291-297
40. Vornehm SI, Dudhia J, Von der Mark K, Aigner T (1996) Expression of collagen types IX and XI and other major cartilage matrix components by human fetal chondrocytes in vivo. Matrix Biol 15:91-98
41. Welkerling H, Kratz S, Ewerbeck V, Delling G (2003) A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data. Virchows Arch 443:725-733